The impact of melphalan dosage on outcomes of autologous haematopoietic cell transplantation for multiple myeloma: Results from the EBMT collaboration to collect autologous transplant outcomes in lymphoma and myeloma (CALM) study

Details

Serval ID
serval:BIB_569E3E9732CF
Type
Inproceedings: an article in a conference proceedings.
Publication sub-type
Abstract (Abstract): shot summary in a article that contain essentials elements presented during a scientific conference, lecture or from a poster.
Collection
Publications
Title
The impact of melphalan dosage on outcomes of autologous haematopoietic cell transplantation for multiple myeloma: Results from the EBMT collaboration to collect autologous transplant outcomes in lymphoma and myeloma (CALM) study
Title of the conference
Bone Marrow Transplantation
Author(s)
Auner H., Iacobelli S., Bianchi G., Knol-Bout C., Blaise D., Russell N., Apperley J., Pohlreich D., Browne P., Kobbe G., Isaksson C., Lenhoff S., Scheid C., Chevallier P., Jantunen E., Anagnostopoulos A., Yakoub-Agha I., Tanase A., Schaap N., Wiktor-Jedrzejczak W., Mayer J., Schoenland S., Morris C., Garderet L., Kroeger N.
Organization
43rd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT)
Address
Marseille, FRANCE
ISSN
0268-3369
Publication state
Published
Issued date
07/2017
Volume
52
Number
Suppl. 1
Pages
S473-S474
Language
english
Web of science
Create date
02/12/2024 16:49
Last modification date
13/12/2024 9:08
Usage data